Prognostic value of the CALLY index in De Novo metastatic colorectal cancer: a retrospective study

Salih Karatlı; İsmail Dilli; Mustafa Altınbaş

doi:10.38053/acmj.1725787

July 28, 2025Anatolian Current Medical Journal

Prognostic value of the CALLY index in De Novo metastatic colorectal cancer: a retrospective study

View at Publisher

Ask AI

Bookmark

Share

Key Points

Patients with elevated CALLY scores exhibited significantly prolonged median progression-free survival of 24 months.
Overall survival analysis revealed a crucial difference in outcomes associated with the CALLY index scores.
Cox regression analysis identified the CALLY index and tumor location as independent prognostic factors.
The study included 108 patients diagnosed with de novo metastatic colorectal cancer using criteria established at the Ankara Etlik City Hospital.

No abstract yet

We only have this paper's title and publication details.

Read it at the source

Implication

Retrospective study finds CALLY index predicts overall survival in patients with metastatic colorectal cancer, suggesting its potential as a prognostic biomarker.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Karatlı et al. (2025) studied this question.

synapsesocial.com/papers/68c1b81854b1d3bfb60ec3f6 https://doi.org/10.38053/acmj.1725787

View at Publisher

Ask AI

Bookmark

Share

Prognostic value of the CALLY index in De Novo metastatic colorectal cancer: a retrospective study

Key Points

No abstract yet

Implication

Discussion

Cite This Study

Prognostic value of the CALLY index in De Novo metastatic colorectal cancer: a retrospective study

Key Points

No abstract yet

Implication

Discussion

Cite This Study

Keep reading

Keep reading